![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Srini Pharmaceuticals Private Limited Choutuppal In, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Pregabalin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2018-169 - Rev 00
This Chemical Type CEP, issued on November 13, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2777 associated with this CEP further emphasizes